Kathy Rickard

744 total citations
24 papers, 589 citations indexed

About

Kathy Rickard is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Kathy Rickard has authored 24 papers receiving a total of 589 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Physiology, 13 papers in Pulmonary and Respiratory Medicine and 2 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Kathy Rickard's work include Asthma and respiratory diseases (17 papers), Respiratory and Cough-Related Research (9 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (7 papers). Kathy Rickard is often cited by papers focused on Asthma and respiratory diseases (17 papers), Respiratory and Cough-Related Research (9 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (7 papers). Kathy Rickard collaborates with scholars based in United States and Sweden. Kathy Rickard's co-authors include Lisa Edwards, Chris Kalberg, Gordon Raphael, Sharon Srebro, Neil Schachter, Mary E. Strek, Ohad Amit, Stephen I. Rennard, Margaret Johnson and Stanley P. Galant and has published in prestigious journals such as The Lancet, CHEST Journal and Journal of Allergy and Clinical Immunology.

In The Last Decade

Kathy Rickard

23 papers receiving 547 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kathy Rickard United States 12 461 432 56 48 48 24 589
T. Svahn United States 6 304 0.7× 255 0.6× 24 0.4× 77 1.6× 29 0.6× 8 510
Nick Adams United Kingdom 13 485 1.1× 476 1.1× 26 0.5× 21 0.4× 57 1.2× 20 601
Iain Small United Kingdom 10 347 0.8× 410 0.9× 72 1.3× 34 0.7× 12 0.3× 23 545
Nada Boudiaf United States 8 251 0.5× 208 0.5× 20 0.4× 23 0.5× 24 0.5× 13 349
R Tammivaara Finland 7 1.1k 2.5× 1.1k 2.5× 154 2.8× 25 0.5× 97 2.0× 11 1.3k
Simon Couillard Canada 15 508 1.1× 473 1.1× 54 1.0× 17 0.4× 15 0.3× 45 675
Peter Dale United Kingdom 11 245 0.5× 202 0.5× 71 1.3× 39 0.8× 32 0.7× 24 412
Luís Pérez de Llano Spain 9 401 0.9× 451 1.0× 11 0.2× 25 0.5× 20 0.4× 21 529
Frank L. Custers Netherlands 8 194 0.4× 327 0.8× 22 0.4× 63 1.3× 21 0.4× 12 442
T Evald Denmark 13 313 0.7× 280 0.6× 10 0.2× 29 0.6× 10 0.2× 18 470

Countries citing papers authored by Kathy Rickard

Since Specialization
Citations

This map shows the geographic impact of Kathy Rickard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathy Rickard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathy Rickard more than expected).

Fields of papers citing papers by Kathy Rickard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathy Rickard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathy Rickard. The network helps show where Kathy Rickard may publish in the future.

Co-authorship network of co-authors of Kathy Rickard

This figure shows the co-authorship network connecting the top 25 collaborators of Kathy Rickard. A scholar is included among the top collaborators of Kathy Rickard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathy Rickard. Kathy Rickard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Alving, Kjell, Robert Anolik, Glenn Crater, Craig LaForce, & Kathy Rickard. (2017). Validation of a New Portable Exhaled Nitric Oxide Analyzer, NIOX VERO®: Randomized Studies in Asthma. Pulmonary Therapy. 3(1). 207–218. 12 indexed citations
4.
Topaz, Maxim, et al.. (2015). Higher 30-day and 60-day readmissions among patients who refuse post acute care services.. PubMed. 21(6). 424–33. 16 indexed citations
5.
Bowles, Kathryn H., Jesse Chittams, Maxim Topaz, et al.. (2015). Successful Electronic Implementation of Discharge Referral Decision Support Has a Positive Impact on 30‐ and 60‐day Readmissions. Research in Nursing & Health. 38(2). 102–114. 40 indexed citations
6.
LaForce, Craig, et al.. (2014). Impact of exhaled nitric oxide measurements on treatment decisions in an asthma specialty clinic. Annals of Allergy Asthma & Immunology. 113(6). 619–623. 23 indexed citations
7.
Rennard, Stephen I., Neil Schachter, Mary E. Strek, Kathy Rickard, & Ohad Amit. (2006). Cilomilast for COPD. CHEST Journal. 129(1). 56–66. 87 indexed citations
8.
Stanford, Richard H., Paul Dorinsky, Courtney Crim, et al.. (2003). Reduction of asthma-related exacerbations and exacerbation-related costs during initial maintenance therapy with fluticasone propionate/salmerol combination product versus montelukast or fluticasone propionate alone. Journal of Allergy and Clinical Immunology. 111(2). S143–S143. 2 indexed citations
9.
Dorinsky, Paul, Steve Yancey, Donna Reilly, Lisa Edwards, & Kathy Rickard. (2003). Long-term effectiveness of the fluticasone propionate/salmeterol (FSC) 100/50 mcg combination product as an inhaled corticosteroid sparing agent. Journal of Allergy and Clinical Immunology. 111(2). S125–S125. 1 indexed citations
10.
Nelson, Harold S., R.A. Nathan, Chris Kalberg, Steve Yancey, & Kathy Rickard. (2001). Comparison of inhaled salmeterol and oral zafirlukast in asthmatic patients using concomitant inhaled corticosteroids.. PubMed. 3(4). 3–3. 31 indexed citations
11.
Raphael, Gordon, Stanley P. Galant, Chris Kalberg, et al.. (2001). Low-dose fluticasone propionate compared with montelukast for first-line treatment of persistent asthma: A randomized clinical trial. Journal of Allergy and Clinical Immunology. 107(3). 461–468. 119 indexed citations
12.
Busse, William W., John H. Wolfe, William W. Storms, et al.. (2001). Fluticasone propionate compared with zafirlukast in controlling persistent asthma: a randomized double-blind, placebo-controlled trial.. PubMed. 50(7). 595–602. 37 indexed citations
13.
Stoloff, Stuart, Sharon Srebro, Lisa Edwards, Margaret Johnson, & Kathy Rickard. (2001). Improved asthma control after changing from low-to-medium doses of other inhaled corticosteroids to low-dose fluticasone propionate.. PubMed. 3(3). 2–2. 2 indexed citations
14.
Bleecker, ER, Michael J. Welch, Chris Kalberg, et al.. (2000). Low-dose inhaled fluticasone propionate versus oral zafirlukast in the treatment of persistent asthma. Journal of Allergy and Clinical Immunology. 105(6). 1123–1129. 105 indexed citations
15.
Raphael, Gordon, et al.. (1999). A comparison of multiple doses of fluticasone propionate and beclomethasone dipropionate in subjects with persistent asthma. Journal of Allergy and Clinical Immunology. 103(5). 796–803. 31 indexed citations
16.
Matz, Jonathan, et al.. (1998). Greater improvement in asthma control with fluticasone propionate than with either zafirlukast or placebo. CHEST Journal. 114. 2 indexed citations
17.
Knobil, Katharine, Chris Kalberg, Amanda Emmett, & Kathy Rickard. (1998). Adding salmeterol is more effective than increasing the dose of fluticasone for patients with asthma who are symptomatic on low dose fluticasone. 29. 19–20. 3 indexed citations
18.
Busse, William W., et al.. (1998). Efficacy, safety, and impact on quality of life of salmeterol in patients with moderate persistent asthma.. PubMed. 4(11). 1579–87. 23 indexed citations
19.
Cox, Felicia, et al.. (1996). 295 The impact of salmeterol versus albuterol on disease specific quality of life in mild to moderate asthmatics. Journal of Allergy and Clinical Immunology. 97(1). 256–256. 8 indexed citations
20.
Vosk, Barbara N., et al.. (1982). A multimethod comparison of popular and unpopular children.. Developmental Psychology. 18(4). 571–575. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by T. Svahn Breakdown of academic impact, for papers by Nick Adams Breakdown of academic impact, for papers by Iain Small Breakdown of academic impact, for papers by Nada Boudiaf Breakdown of academic impact, for papers by R Tammivaara Breakdown of academic impact, for papers by Simon Couillard Breakdown of academic impact, for papers by Peter Dale Breakdown of academic impact, for papers by Luís Pérez de Llano Breakdown of academic impact, for papers by Frank L. Custers Breakdown of academic impact, for papers by T Evald
Rankless by CCL
2026